A significantly higher level of UBE2C mRNA was observed in ovarian cancer (OV; p < 0.01) (Figure 2C) and other cancer types, such as lymphoid neoplasm diffuse large B-cell lymphoma (DLBC; p < 0.01), acute myeloid leukemia (LAML; p < 0.01), thymoma (THYM; p < 0.01), skin cutaneous melanoma (SKCM; p < 0.01), advanced colorectal carcinoma (ACC; p < 0.01), uterine carcinosarcoma (UCS; p < 0.01), lower grade brain glioma (LGG; p < 0.01), testicular germ cell tumors (TGCT; p < 0.01), and sarcoma (SARC; p < 0.01), than in the corresponding normal tissues (Figure S3A). This evidence concerns the gene UBE2C and sarcoma.